In 2011, McMahon et al.16
| Active Ingredient | Dosage | Manufacturer | Typical Use Cases | Price Range |
|---|---|---|---|---|
| Dapoxetine | 60 mg | Various | Premature Ejaculation | $30 - $60 |
| Dapoxetine | 60 mg | Various | Premature Ejaculation | $30 - $60 |
| Dapoxetine | 60 mg | Various | Premature Ejaculation | $30 - $60 |
published an integrated analysis of results
from five phase 3 trials
Among these studies, we carried out a subgroup analysis based on PE patients treated with dapoxetine 30 mg and 60 mg on-demand oral administration. A statistically significant difference was found in the subgroup treated with 30 mg dapoxetine compared with the placebo-treated group (MD = 1.16; 95% CI = 0.94–1.38; P < 0.00001). The subgroup analysis of the dapoxetine group treated with 60 mg compared with placebo also reporting IELT also revealed a statistically significant difference in patient response (MD = 1.63; 95% CI = 1.41–1.84; P < 0.00001). In addition, five studies9,12,13,14,15 including a total of 3346 patients, we pooled to compare IELT; patients were divided into two groups treated with either 60 mg or 30 mg dapoxetine. In the fixed-effect model meta-analysis of the five studies, the pooled estimates were statistically significantly different between the dapoxetine 60 mg and 30 mg groups (MD = 0.39; 95% CI = 0.23–0.56; P < 0.00001; Figure 4).
This pooled analysis indicated that the dapoxetine 60 mg group was associated with a markedly longer IELT than the dapoxetine 30 mg group. Three studies9,12,13 including 2950 patients compared the PGIC in dapoxetine 30 mg and placebo subgroups and four studies9,10,12,13 including 3567 patients compared PGIC in dapoxetine 60 mg and a placebo subgroup. Pooled analysis indicated that when compared to the placebo group, there was a significantly higher proportion of PGIC in the dapoxetine group. The overall risk ratio (RR) was 2.14 (95% CI = 1.90–2.42; P < 0.00001). The subgroup analysis indicated a statistically significant difference between the dapoxetine (for both 30 mg and 60 mg groups) and the placebo group in PGIC (RR = 2.01, 95% CI = 1.69–2.38, P < 0.00001; and RR = 2.26, 95% CI = 1.91–2.67, P < 0.00001, respectively; Figure 5). attempting to explore the efficacy and
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 50mg | 360 + 10 Pills | 225.33€ 214.60€ | |
| Levitra Soft Tabs | 20mg | 20 Pills | 74.68€ 71.12€ | |
| Priligy Generic Dapoxetine | 60mg | 120 + 10 Pills | 341.26€ 325.01€ | |
| Priligy Generic Dapoxetine | 60mg | 90 + 10 Pills | 265.64€ 252.99€ | |
| Kamagra Soft Tabs | 100 mg | 180 + 8 Pills | 425.45€ 405.19€ | |
| Priligy Generic Dapoxetine | 60mg | 30 + 6 Pills | 106.65€ 101.57€ | |
| Priligy Generic Dapoxetine | 60mg | 10 Pills | 47.63€ 45.36€ | |
| Priligy Generic Dapoxetine | 60mg | 60 + 8 Pills | 183.06€ 174.34€ | |
| Kamagra Gold | 100 mg | 180 + 6 Pills | 436.79€ 415.99€ | |
| Priligy Generic Dapoxetine | 60mg | 20 + 4 Pills | 77.31€ 73.63€ | |
| Priligy Generic Dapoxetine | 60mg | 180 + 10 Pills | 494.76€ 471.20€ | |
| Cialis Generic | 10mg | 360 + 10 Pills | 388.49€ 369.99€ | |
| Levitra Soft Tabs | 20mg | 120 + 8 Pills | 288.52€ 274.78€ | |
| Cialis Original | 20mg | 92 + 4 Pills | 377.99€ 359.99€ |
safety of dapoxetine for treatment
Selective serotonin reuptake inhibitors (SSRIs) have become the most widely used medicine in the world7. Dapoxetine hydrochloride, belonging to the class of SSRIs, was the first drug originally approved for the on-demand treatment of men with PE by seven European countries in 20088. Unfortunately, the efficacy and safety of dapoxetine (30 mg and 60 mg on-demand) has never been comprehensively studied in men with PE. Most data derived from clinical studies in men with PE are available. The objective of this study was to not only evaluate the efficacy and safety of dapoxetine when used at either dapoxetine 30mg tablet 30 mg or 60 mg as compared with the placebo as an oral on-demand treatment in men with PE in routine clinical practice by performing a meta-analytic synthesis of studies, but also to assess whether there are differences in efficacy and safety for PE treatment using either 30 mg or 60 mg dapoxetine.
The electronic and manual searches of PubMed, EMBASE and Cochrane Central Register of Controlled Trials (Cochrane Library) databases resulted in 106 references, of which 88 were clearly not relevant to our study. Of the remaining 18 references, 11 were excluded after reading the full text. After a quality validation, only seven studies9,10,11,12,13,14,15 were selected from the literature search. The flow chart of the evidence acquisition process is summarized in Figure 1 and the methodological quality of the included studies is reported in Figure 2. Seven randomized controlled trials (RCTs) involving 8039 PE patients met the inclusion criteria.
Of these, 2478, 2932 and 2629 patients received 30 mg dapoxetine, 60 mg dapoxetine, or the placebo, respectively. The study included patients aged 18 years or older and the patients were randomized for dapoxetine 30 mg or dapoxetine 60 mg or placebo administration on-demand (1–3 hours prior to anticipated sexual activity). The basic characteristics of the included studies are summarized in Table 1. Three of the RCTs selected9,12,13 evaluating dapoxetine versus placebo for PE reported IELT as the primary outcome. Our pooled analysis showed that PE in patients in the dapoxetine group showed a significant improvement in IELT when compared to patients in the placebo group (mean difference [MD] = 1.39; 95% confidence interval [95% CI] = 1.24–1.55; P < 0.00001). of PE and they proposed that
| Platform | Country Access | Payment Methods | User Ratings | Delivery Time |
|---|---|---|---|---|
| Pharmacity | Global | Credit Card, PayPal | 4.5/5 | 3-7 days |
| MedExpress | Global | Bitcoin, Credit Card | 4.2/5 | 5-10 days |
| BuyMeds | Global | Credit Card, Ethereum | 4.0/5 | 4-8 days |
dapoxetine significantly improved all aspects of
Furthermore, AEs were assessed in six studies9,11,12,13,14,15 comparing two dapoxetine dosages (60 mg vs. 30 mg). This present plot demonstrated that a statistically significant difference existed between the 60 mg and 30 mg group in terms of the incidence of AEs (RR = 1.57; 95% CI = 1.31–1.89; P < 0.00001; Figure 8). Dapoxetine hydrochloride was the first drug originally approved for the on-demand treatment of patients with PE in 2008. Since then, it has received marketing authorization in 59 countries worldwide7,8. PE and was generally well tolerated.
All orders are dispensed by our pharmacist and delivered in plain, discreet packaging - so there is no need to visit a GP surgery or pharmacy in person. Yes , psychological factors are among the most common causes of premature ejaculation. Performance anxiety, stress, relationship difficulties, and low confidence can all contribute to or worsen PE. This is especially true for men experiencing it at the start of a new relationship or following a period of sexual inactivity. In many cases, a combination of effective treatment alongside techniques such as the stop-start method, pelvic floor exercises, or psychosexual counselling can produce the best long-term results.
If you feel your PE is primarily psychological in nature, it is worth mentioning this during your online consultation so your prescriber can provide the most appropriate advice. I'm pleased to say I am totally satisfied with the professional way I was treated. UK Registered Pharmacy The MHRA regulates medicines and medical devices in the UK. The MHRA regulates medicines and medical devices in the UK. GPhC Regulated Pharmacy The GPhC regulates pharmacists, pharmacy technicians and pharmacies in Great Britain.
The GPhC regulates pharmacists, pharmacy technicians and pharmacies in Great Britain. PCI DSS Compliant PCI DSS is an information security standard for organisations that handle credit card payments. PCI DSS is an information security standard for organisations that handle credit card payments. ICO Registered Website The UK's independent authority set up to uphold information rights in the public interest. The UK's independent authority set up to uphold information rights in the public interest.
